The CDC reported Jan. 13 that 29 states were reporting “high” levels of respiratory illness activity.
Six states reported “very high” levels of respiratory illness activity: Arizona, Oklahoma, Kentucky, New Hampshire, Delaware and Hawaii.
Here are five more updates from the CDC report:
- Emergency department visits were high, while RSV visits remained very high. COVID-19-related ED visits were also elevated across the country.
- Influenza test positivity remained stable at 18.6%, while COVID-19 remained steady at 6.9%. The RSV positivity rate increased to 11.6%.
- COVID-19 and influenza A were at high levels in wastewater samples, while RSV activity was moderate.
- Emergency department data suggests a potential decline in COVID-19 and flu cases in the coming weeks. However, the overall impact may be influenced by data reporting delays and changes in healthcare behavior during the holidays.
- Hospitals across the country are facing significant capacity challenges with multiple viral infections surging, driving up patient numbers. Emergency departments are particularly overwhelmed, with hospitals such as Edina, Minn.-based M Health Fairview having to use hallways and nontraditional spaces to treat patients. In Minnesota, flu-related hospital admissions are nearing the highest levels seen in five years.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
